Adenosine deaminase (ADA) is an enzyme abundant in activated T lymphocytes. Therefore, its concentration rises in body fluids during cell-mediated immune responses, especially tuberculosis (TB). It is a supportive diagnostic test, not a stand-alone microbiologic confirmation.
| Specimen | Main significance | Common diagnostic cutoff | Interpretation |
|---|
| Pleural fluid | Supports diagnosis of tuberculous pleural effusion (TPE) | Usually ≥40 U/L | Strongly favors TPE when the fluid is an exudate with lymphocyte predominance |
| CSF | Supports diagnosis of tuberculous meningitis (TBM) | Often about >10 U/L, but assay- and setting-dependent | Raises probability of TBM; cannot exclude TBM if normal |
1. ADA in pleural fluid
Primary use
Pleural-fluid ADA is most useful for diagnosing tuberculous pleuritis / tuberculous pleural effusion, particularly in a patient with:
- Exudative pleural effusion
- Lymphocyte predominance
- Epidemiologic or clinical risk for TB
- Negative or pending pleural fluid AFB smear/culture, which are often insensitive
An ADA of ≥40 U/L is a commonly used threshold. A textbook source reports sensitivity of 88% to 99% and specificity of 88% to 97% at this cutoff for tuberculous pleurisy. Symptom to Diagnosis: An Evidence-Based Guide, p. 209.
How to interpret it
- High ADA with lymphocytic exudate: supports TB strongly, especially in a high-prevalence setting.
- Low ADA, particularly <40 U/L, makes TB less likely in an immunocompetent person with a lymphocytic effusion.
- It should be interpreted with Light's criteria, differential cell count, imaging, sputum examination, mycobacterial culture/NAAT, and, if needed, pleural biopsy.
Causes of false elevation
ADA is not specific for TB. It may also be high in:
- Empyema and complicated parapneumonic effusion
- Lymphoma
- Rheumatoid pleuritis
- Some malignant effusions
- Other inflammatory or granulomatous diseases
A high result in a neutrophil-predominant fluid is less helpful because bacterial pleural infection can markedly increase ADA.
2. ADA in CSF
Primary use
CSF ADA is used as an adjunct in suspected tuberculous meningitis, a condition where delayed treatment can cause severe neurologic injury or death.
TB activates T-cell-mediated immunity in the meninges, leading to raised CSF ADA. Laboratory references describe its use in pleural, peritoneal, and meningeal tuberculosis, while cautioning that it has limited utility in HIV-associated neurologic disease. Henry's Clinical Diagnosis and Management by Laboratory Methods.
Cutoff and diagnostic value
There is no universal cutoff because values vary with assay method, population, age, TB prevalence, and comparator diseases. A cutoff around 10 U/L is commonly used in many studies.
A recent adult systematic review found that at cutoffs below 10 U/L, pooled sensitivity was about
82% and specificity about
90%; at cutoffs above 10 U/L, sensitivity was about
85% and specificity about
88%. The certainty of evidence was rated very low because of study heterogeneity, so ADA cannot serve as the sole diagnostic test. See this
CSF ADA meta-analysis.
How to interpret it
A raised CSF ADA supports TBM when combined with the typical CSF pattern:
- Lymphocytic pleocytosis, although early disease may be neutrophilic
- High protein
- Low CSF glucose or low CSF:serum glucose ratio
- Basal meningeal enhancement, hydrocephalus, infarcts, or tuberculomas on neuroimaging
- Positive CSF Xpert MTB/RIF Ultra, NAAT, AFB smear, or culture
Important: A low CSF ADA does not rule out TBM. Suspected TBM often warrants urgent empiric treatment while confirmatory testing proceeds.
Causes of false elevation / limitations
CSF ADA may also rise in:
- Bacterial meningitis
- Fungal meningitis
- Neurobrucellosis and other chronic infections
- Lymphomatous or malignant meningitis
- Other inflammatory CNS disorders
Thus, its value is greater as a rule-in supportive test than as an isolated exclusion test.
Key comparison
- Pleural ADA: more established, generally performs well in the appropriate setting, especially a lymphocytic exudative effusion.
- CSF ADA: useful adjunct for TBM but more variable. Never use it alone to confirm or exclude TBM.
- For either fluid, ADA reflects inflammation and T-cell activity, not direct detection of Mycobacterium tuberculosis. Microbiologic testing and clinical context remain necessary.
Recent evidence supports the continuing usefulness of CSF ADA but also reinforces the variability across studies, including the 2023 meta-analysis
PMID 36591905.